Effectiveness of Cognitive Training in Older and Younger Adults

NCT ID: NCT06375681

Last Updated: 2025-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-01

Study Completion Date

2028-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed study will enroll 1600 participants to examine the effectiveness of cognitive training. Participants will be randomized into different experimental groups and can expect to participate for up to 15 hours of research over 4 to 8 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will first complete two sessions (\~75 minutes each) where they are asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers. They will be asked to make some simple judgments about the stimuli (such as indicating whether the stimulus you observed is the same or different from that on a previous trial), and indicate their judgment decision with a button press on a keyboard, a mouse click, or a movement on a touchpad. They will also be asked to complete a set of questionnaires.

After the initial sessions, participants may be asked to complete two sets of 10 sessions (\~20 minutes) of cognitive tasks either at home or in the lab. Each set of sessions should be completed over a period of no more than 15 days. If asked to do these sessions, instructions will be given regarding the tasks to complete in these training sessions (which will be similar to some of the tasks you complete in the first two sessions, \~20 minutes) prior to these sessions.

After completing the first set of 10 sessions, participants will complete, either at home or in the lab, one session (\~75 minutes) of tasks similar to the first sessions. Participants who were not asked to complete the 20-minute sessions will complete another session two weeks after the first two 75-minute sessions in the same location as they completed the two 75-minute sessions.

Then, participants will complete the second set of ten 20-minute sessions, or wait for about two weeks for those not asked to complete the 20-minute sessions of cognitive tasks. After this, participants will complete two other sessions (\~75 minutes) in the same location as they completed the previous two 75-mintue sessions.

Finally, after a couple of weeks, participants will complete their two final testing sessions (\~45 minutes each) in the same location as they completed the previous two 75-mintue sessions.

The total duration of the study will be around 8 hours if not asked to complete the twenty 20-minute sessions, or 15 hours if asked to complete these sessions. The whole experiment runs over the course of 4 to 8 weeks.

\*To maintain scientific integrity, certain details of this study will not be shared until all data has been collected.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Change

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Cognitive Training Training task Testing context

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Following Pre-testing, participants randomly assigned into the full study will be further randomly assigned to a total of 9 unique experimental conditions for the full 2x2x2+1 factorial design.

The full description of the study's 9 arms will be registered after data collection is completed to preserve the scientific integrity of the study.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors
All researchers that have contact with participants will be unaware of the tested hypothesis of the study.

Participants will be unaware of the experimental conditions.

Researchers and participants will be unaware (blinded) to the game conditions assigned to the participant, except for researchers in charge of supervising the training part of the study who will be aware what training the participant is undergoing.

More information on how this was achieved will be registered after data collection is completed to preserve the scientific integrity of the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Short Testing Group

Participants will go through 2 assessment sessions over 2-3 days (\~75 minutes each), followed by 1 session of 75 minutes about 2 weeks later, 2 further sessions (\~75 minutes) over 2-3 days about 2 weeks after this session, and finally another 2 sessions (\~45 minutes) 3 days to 2 weeks after that session. Sessions might take place either at home or in the lab.

Group Type ACTIVE_COMPARATOR

Visual and / or Auditory Cognitive Tasks (1)

Intervention Type BEHAVIORAL

Seven sessions (\~45-75 minutes) of cognitive tasks in the lab.

Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.

Long Testing Group

Participants will go through 2 assessment sessions over 2-3 days (75 minutes each), followed by 10 sessions of cognitive tasks over 2 weeks, 1 session of 75 minutes about 2 weeks later, another 10 sessions of cognitive tasks over 2 weeks, then 2 sessions (\~75 minutes) over 2-3 days about 2 weeks after this session, and finally another 2 sessions (\~45 minutes) 3 days to 2 weeks after that session. Sessions might take place either at home or in the lab.

Group Type ACTIVE_COMPARATOR

Visual and / or Auditory Cognitive Tasks (1)

Intervention Type BEHAVIORAL

Seven sessions (\~45-75 minutes) of cognitive tasks in the lab.

Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.

Visual and / or Auditory Cognitive Tasks (2)

Intervention Type BEHAVIORAL

Two sets of 10 sessions (\~20 minutes) of cognitive tasks either at home or in the lab.

Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Visual and / or Auditory Cognitive Tasks (1)

Seven sessions (\~45-75 minutes) of cognitive tasks in the lab.

Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.

Intervention Type BEHAVIORAL

Visual and / or Auditory Cognitive Tasks (2)

Two sets of 10 sessions (\~20 minutes) of cognitive tasks either at home or in the lab.

Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Self-reported normal or corrected-to-normal vision
* No known neurological impairments

Exclusion Criteria

* Abnormal visual acuity prohibitive of training
* History of seizures, focal brain lesion, or head injury with loss of consciousness in the past year
* Physical handicap (motor or perceptual) that would impede training procedures
* Medical illness requiring treatment during the study timeline
* Social, educational or economic hardship prohibitive to training schedule
* Concurrent enrollment in other cognitive training studies
* History of major psychiatric illness, including psychosis, bipolar disorder, alcohol or substance abuse, recent bereavement
* Score of 5 or more (i.e. presence of mild, moderate, or severe depression) on the Patient Health Screening Questionnaire (PHQ-9 Depression Screening); any participants reporting suicidal tendencies will be immediately referred to the site-specific Emergency Psychiatry Services (24-hour availability), and those with high depressive symptoms will be referred to their personal physician
* Current alcohol consumption that exceeds 14 drinks per week
* Illicit drug use
* Plans to travel out of the area for more than 1 week during the intervention period
* Residence too far from the testing site, which would prevent attending the testing sessions (\> 60 miles)
* Not being proficient enough in English that would prevent following and understanding all instructions and completing all testing sessions (typically, participants would need to have learned English before age 11; there might be some exceptions that will be decided on a case-by-case basis).


* Diagnosis of dementia or other neurological disease, including mild cognitive impairment (MCI)
* Score \< 26 (out of 30) on the Mini Mental State Exam (MMSE)
* Score \< 18 (out of 22) on the Telephone Montreal Cognitive Assessment (T-MoCA).
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aaron R. Seitz, PhD

Role: PRINCIPAL_INVESTIGATOR

University of California, Riverside

Susanne M. Jaeggi, PhD

Role: PRINCIPAL_INVESTIGATOR

Northeastern University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California, Riverside

Riverside, California, United States

Site Status RECRUITING

Northeastern University

Boston, Massachusetts, United States

Site Status RECRUITING

University of Wisconsin - Madison

Madison, Wisconsin, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

C. Shawn Green, PhD

Role: CONTACT

Phone: (608) 263-4868

Email: [email protected]

Freya Joessel, PhD

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aaron Seitz, PhD

Role: primary

Susanne Jaeggi, PhD

Role: primary

C. Shawn Green, PhD

Role: primary

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01AG076157-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

A487400

Identifier Type: OTHER

Identifier Source: secondary_id

2019-1378: R01

Identifier Type: -

Identifier Source: org_study_id